Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anca Leibovici"'
Autor:
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Mahmoud Abu Amna, Anton Ouryvaev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Luiza Akria, Dimitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Gil Bar-Sela, David Meiri
Publikováno v:
Frontiers in Pain Research, Vol 3 (2022)
The use of medical cannabis (MC) to treat cancer-related symptoms is rising. However, there is a lack of long-term trials to assess the benefits and safety of MC treatment in this population. In this work, we followed up prospectively and longitudina
Externí odkaz:
https://doaj.org/article/0e62212239e74aa79ad8acd7045b712e
Autor:
Atara Uzan-Yulzari, Maya Morr, Hala Tareef-Nabwani, Oren Ziv, Dafna Magid-Neriya, Ran Armoni, Efrat Muller, Anca Leibovici, Elhanan Borenstein, Yoram Louzoun, Ayelet Shai, Omry Koren
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background Adjuvant chemotherapy induces weight gain, glucose intolerance, and hypertension in about a third of women. The mechanisms underlying these events have not been defined. This study assessed the association between the microbiome a
Externí odkaz:
https://doaj.org/article/3a970d10f0d64c0eba766bf3f38fa50c
Autor:
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Anton Uribayev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Mahmud Abo-Amna, Luiza Akria, Dmitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Or Hazan, Gil Bar-Sela, David Meiri
Publikováno v:
Pharmaceuticals, Vol 13, Iss 12, p 435 (2020)
In the last decade the use of medical cannabis (MC) for palliative cancer treatment has risen. However, the choice between products is arbitrary and most patients are using Tetrahydrocannabinol (THC)-dominant cannabis products. In this study, we aime
Externí odkaz:
https://doaj.org/article/d74e246789a745cbb048bc92c942b028
Publikováno v:
Biologics: Targets and Therapy. 17:61-67
Ruth Percik,1â 3 Cecilie Oedegaard Smith,3,4 Anca Leibovici,5,6 Ayelet Shai7 1Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Ramat Gan, Israel; 2Endo-Oncology Clinic, Sheba Medical Center, Ramat Gan, Israel; 3Sackler F
Autor:
Elhanan Borenstein, Atara Uzan-Yulzari, Hala Tareef-Nabwani, Anca Leibovici, Oren Ziv, Efrat Muller, Ran Armoni, Yoram Louzoun, Maya Morr, Omry Koren, Ayelet Shai, Dafna Magid-Neriya
Publikováno v:
BMC Medicine
BMC Medicine, Vol 18, Iss 1, Pp 1-10 (2020)
BMC Medicine, Vol 18, Iss 1, Pp 1-10 (2020)
Background Adjuvant chemotherapy induces weight gain, glucose intolerance, and hypertension in about a third of women. The mechanisms underlying these events have not been defined. This study assessed the association between the microbiome and weight
Publikováno v:
The Israel Medical Association journal : IMAJ. 20(12)
Brain-derived neurotrophic factor (BDNF) is a neuronal growth factor that is important for the development, maintenance, and repair of the peripheral nervous system. The BDNF gene commonly carries a single nucleotide polymorphism (Val66Met-SNP), whic
Autor:
Dmitry Goncharov, Anca Leibovici, Shiri Procaccia, Mahmud Abo-Amna, Gil Bar-Sela, Joshua Aviram, David Meiri, Or Hazan, Ayelet Shai, Anton Uribayev, Idan Cohen, Gil M. Lewitus, Luiza Akria, Neomi Mativ, Yelena Vysotski, Avia Kauffman
Publikováno v:
Pharmaceuticals
Volume 13
Issue 12
Pharmaceuticals, Vol 13, Iss 435, p 435 (2020)
Volume 13
Issue 12
Pharmaceuticals, Vol 13, Iss 435, p 435 (2020)
In the last decade the use of medical cannabis (MC) for palliative cancer treatment has risen. However, the choice between products is arbitrary and most patients are using Tetrahydrocannabinol (THC)-dominant cannabis products. In this study, we aime
Autor:
Deborah T. Blumenthal, Leor Zach, Zvi Ram, Alisa Taliansky, Rachel Grossman, Alexander Lossos, Anca Leibovici, Shlomit Yust-Katz, Felix Bokstein, Alejandro Lokiec, Tali Siegal, Tzahala Tzuk-Shina, Itay Forschner
Publikováno v:
Neuro-Oncology. 20:vi119-vi119
BACKGROUND: TTFields are low intensity, intermediate frequency alternating electric fields, delivered through a portable, non-invasive device (Optune, Novocure(TM)). The EF-14 phase III trial showed significant prolongation of both progression-free a
Autor:
Eti Shaoul, Anca Leibovici, Rivka Sharoni, Andrei Braester, Hadassah Goldberg, Bella Gross, David Azoulay
Publikováno v:
Breast cancer research and treatment. 153(3)
Publikováno v:
Journal of Clinical Oncology. 35:e21702-e21702
e21702 Background: We previously published preliminary results suggesting an association between the met-BDNF allele and vulnerability to paclitaxel-induced peripheral neuropathy (PIPN) in breast cancer patients. Here we present updated data obtained